DekaBank Deutsche Girozentrale’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.98M Sell
12,211
-124
-1% -$30.3K 0.01% 670
2025
Q1
$2.97M Buy
12,335
+124
+1% +$29.8K 0.01% 662
2024
Q4
$3.98M Hold
12,211
0.01% 623
2024
Q3
$4.03M Sell
12,211
-3,376
-22% -$1.11M 0.01% 627
2024
Q2
$4.23M Buy
15,587
+3,252
+26% +$882K 0.01% 617
2024
Q1
$4.3M Sell
12,335
-914
-7% -$319K 0.01% 607
2023
Q4
$4.25M Sell
13,249
-92
-0.7% -$29.5K 0.01% 615
2023
Q3
$4.74M Buy
13,341
+4,325
+48% +$1.54M 0.01% 555
2023
Q2
$3.38M Sell
9,016
-559
-6% -$210K 0.01% 640
2023
Q1
$4.48M Sell
9,575
-379
-4% -$177K 0.01% 561
2022
Q4
$4.21M Buy
9,954
+1,976
+25% +$835K 0.01% 578
2022
Q3
$3.31M Buy
7,978
+256
+3% +$106K 0.01% 601
2022
Q2
$3.76M Sell
7,722
-1,012
-12% -$493K 0.01% 591
2022
Q1
$5.06M Sell
8,734
-43
-0.5% -$24.9K 0.01% 561
2021
Q4
$6.62M Sell
8,777
-465
-5% -$351K 0.02% 505
2021
Q3
$6.91M Buy
9,242
+32
+0.3% +$23.9K 0.02% 461
2021
Q2
$5.84M Sell
9,210
-120
-1% -$76.1K 0.02% 488
2021
Q1
$5.24M Buy
9,330
+482
+5% +$271K 0.02% 472
2020
Q4
$5.07M Sell
8,848
-3,275
-27% -$1.88M 0.02% 450
2020
Q3
$6.14M Buy
12,123
+587
+5% +$297K 0.03% 359
2020
Q2
$5.03M Buy
11,536
+1,914
+20% +$834K 0.03% 319
2020
Q1
$3.32M Sell
9,622
-639
-6% -$220K 0.03% 332
2019
Q4
$3.75M Buy
10,261
+1,088
+12% +$397K 0.02% 384
2019
Q3
$3.08M Sell
9,173
-720
-7% -$242K 0.02% 444
2019
Q2
$3.05M Buy
9,893
+2,043
+26% +$631K 0.02% 533
2019
Q1
$2.56M Sell
7,850
-300
-4% -$97.7K 0.02% 553
2018
Q4
$1.88M Buy
8,150
+300
+4% +$69.1K 0.01% 549
2018
Q3
$2.56M Hold
7,850
0.02% 566
2018
Q2
$2.28M Sell
7,850
-600
-7% -$174K 0.01% 554
2018
Q1
$2.11M Sell
8,450
-1,150
-12% -$287K 0.01% 560
2017
Q4
$2.06M Hold
9,600
0.02% 538
2017
Q3
$2.06M Hold
9,600
0.02% 546
2017
Q2
$2.16M Hold
9,600
0.02% 531
2017
Q1
$1.92M Buy
+9,600
New +$1.92M 0.02% 493